The Mepolizumab Pregnancy Exposure Study: a VAMPSS post marketing surveillance study of Mepolizumab safety in pregnancy (200870 NPSS (Nucala Pregnancy Surveillance Study))

First published 13/06/2016

Last updated 09/08/2024

EU PAS number:

EUPAS13772

Study

Finalised

Documents

Study protocol

Initial protocol

gsk-200870-protocol-redact

English (1.18 MB - PDF) View document

Updated protocol

gsk-200870-protocol-redact-v02

First published: 22/02/2024

English (6.95 MB - PDF) View document

Study results

Study report

Clinical Study Report Anonymized 29 Jul 2024.pdf

English (3.79 MB - PDF) View document

Other information

Secondary tabs